Refine my results

Prevalence of physiological uptake in the pancreas on somatostatin receptor-based PET/CT : a systematic review and a meta-analysis

Boughdad, Sarah ; Meyer, Marie ; Prior, John O. ; Fernandes, Victor ; Allenbach, Gilles ; Kamani, Christel ; Jreige, Mario ; Albano, Domenico ; Bertagna, Francesco ; Nicod-Lalonde, Marie ; Schaefer, Niklaus ; Treglia, Giorgio

In: Clinical and Translational Imaging, 2021, vol. 9, no. 4, p. 353–360

Background: Physiological focal radiopharmaceutical uptake in the head and uncinate process of the pancreas may be seen on somatostatin receptor-based PET/CT and might lead to false-positive results for neuroendocrine tumours (NETs). We aimed to perform a systematic review and a meta-analysis about the prevalence of this finding. Methods: We performed a comprehensive computer literature search...

Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate

Müller, Cristina ; Reber, Josefine ; Haller, Stephanie ; Dorrer, Holger ; Bernhardt, Peter ; Zhernosekov, Konstantin ; Türler, Andreas ; Schibli, Roger

In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 3, p. 476-485

Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy

Wang, Xuejuan ; Fani, Melpomeni ; Schulz, Stefan ; Rivier, Jean ; Reubi, Jean ; Maecke, Helmut

In: European Journal of Nuclear Medicine and Molecular Imaging, 2012, vol. 39, no. 12, p. 1876-1885

Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans

Waser, Beatrice ; Reubi, Jean

In: European Journal of Nuclear Medicine and Molecular Imaging, 2011, vol. 38, no. 6, p. 1054-1058

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Antunes, P. ; Ginj, M. ; Zhang, H. ; Waser, B. ; Baum, R. ; Reubi, J. ; Maecke, H.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2007, vol. 34, no. 7, p. 982-993

Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog

Reubi, Jean ; Erchegyi, Judit ; Cescato, Renzo ; Waser, Beatrice ; Rivier, Jean

In: European Journal of Nuclear Medicine and Molecular Imaging, 2010, vol. 37, no. 8, p. 1551-1558

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Wild, Damian ; Schmitt, Jörg ; Ginj, Mihaela ; Mäcke, Helmut ; Bernard, Bert ; Krenning, Eric ; de Jong, Marion ; Wenger, Sandra ; Reubi, Jean-Claude

In: European Journal of Nuclear Medicine and Molecular Imaging, 2003, vol. 30, no. 10, p. 1338-1347

Copper-67 as a therapeutic nuclide for radioimmunotherapy

Novak-Hofer, Ilse ; Schubiger, August

In: European Journal of Nuclear Medicine and Molecular Imaging, 2002, vol. 29, no. 6, p. 821-830

Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy

Müller, Cristina ; Mindt, Thomas ; de Jong, Marion ; Schibli, Roger

In: European Journal of Nuclear Medicine and Molecular Imaging, 2009, vol. 36, no. 6, p. 938-946

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

Zhang, Hanwen ; Schuhmacher, Jochen ; Waser, Beatrice ; Wild, Damian ; Eisenhut, Michael ; Reubi, Jean ; Maecke, Helmut

In: European Journal of Nuclear Medicine and Molecular Imaging, 2007, vol. 34, no. 8, p. 1198-1208